Rv0956 Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2)

Summary

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv0956 purN Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) CDS 1067561 1068208 + 648 215 FALSE

Rv0956 (Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2)) is predicted to be co-regulated in modules bicluster_0317 with residual 0.52 and bicluster_0334 with residual 0.56.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 12,000.00 and 12,000.00 for bicluster_0317 and 0.06 and 520.00 for bicluster_0334 respectively.

These modules are enriched for following go terms: flavin adenine dinucleotide binding .

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
PROBABLE 5&apos-PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE PURN [GART] [GAR TRANSFORMYLASE] [5&apos-PHOSPHORIBOSYLGLYCINAMIDE TRANSFORMYLASE] phosphoribosylglycinamide formyltransferase
Operon # Operon
638 -
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

Purine metabolism

65
Total items in this category:  

KEGG

One carbon pool by folate

13
Total items in this category:  

KEGG

Metabolic pathways

601
Total items in this category:  

KEGG

Biosynthesis of secondary metabolites

326
Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15608096 NP_215471.1 Run
GO:0004644

phosphoribosylglycinamide formyltransferase activity

phosphoribosylglycinamide formyltransferase activity

Details: 
Catalysis of the reaction: 10-formyltetrahydrofolate + N1-(5-phospho-D-ribosyl)glycinamide = tetrahydrofolate + N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide.
GO Category: 
molecular_function
1
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
NA NA

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: